About this FactMed analysis covering adverse side effect reports of ALMARL patients who developed PARKINSONISM.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ALMARL reported PARKINSONISM to the FDA. A total of 227 ALMARL drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ALMARL and PARKINSONISM. In doing so, we compare ALMARL with other drugs that cause PARKINSONISM, to help you evaluate whether or not ALMARL causes PARKINSONISM. Likewise, this page shows the most highly-reported side effects of ALMARL, so you can see if PARKINSONISM ranks among ALMARL's most well-known side effects.
Summary Statistics
Reports of ALMARL causing PARKINSONISM: 1
Reports of any side effect of ALMARL : 227
Percentage of ALMARL patients where PARKINSONISM is a reported side effect: 0.4405%

FDA reports of any drug causing PARKINSONISM : 3094
Average percentage for all medicated patients where PARKINSONISM is reported as a complication: 0.0194%

Physician opinion on ALMARL as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ALMARL:
HYPERTENSION ( 76 patients )
PARKINSON'S DISEASE ( 8 patients )
ESSENTIAL TREMOR ( 6 patients )
ATRIAL FIBRILLATION ( 4 patients )
SCHIZOPHRENIA ( 2 patients )
TREMOR ( 2 patients )
ANGINA PECTORIS ( 2 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2 patients )
PALPITATIONS ( 2 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
TACHYCARDIA ( 2 patients )
HYPERTROPHY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with PARKINSONISM:

METOCLOPRAMIDE (410 patients)
RISPERDAL (377 patients)
SEROQUEL (261 patients)
ABILIFY (215 patients)
ASPIRIN (207 patients)
ZYPREXA (189 patients)
PAXIL (182 patients)
HALDOL (171 patients)
REGLAN (168 patients)
RISPERIDONE (144 patients)
LORAZEPAM (131 patients)
METOCLOPRAMIDE HYDROCHLORIDE (112 patients)
LITHIUM CARBONATE (108 patients)
DEPAKENE (107 patients)
LYRICA (102 patients)
FOSAMAX (98 patients)
OLANZAPINE (96 patients)
DIAZEPAM (94 patients)
CLOZARIL (91 patients)
EFFEXOR XR (91 patients)
ARICEPT (91 patients)
AMLODIPINE (89 patients)
HALOPERIDOL (88 patients)
MIRTAZAPINE (83 patients)
LIPITOR (81 patients)
CLONAZEPAM (79 patients)
ZOLOFT (75 patients)
CITALOPRAM HYDROBROMIDE (74 patients)
SINEMET (73 patients)
OMEPRAZOLE (68 patients)
NORVASC (67 patients)
FUROSEMIDE (66 patients)
DIGOXIN (62 patients)
SIMVASTATIN (58 patients)
LAMICTAL (57 patients)
DEPAKOTE (56 patients)
GEODON (53 patients)
ALPRAZOLAM (53 patients)
EFFEXOR (52 patients)
LEVOTHYROXINE SODIUM (52 patients)
LISINOPRIL (52 patients)
VALPROIC ACID (52 patients)
REQUIP (50 patients)
AKINETON (49 patients)
GABAPENTIN (48 patients)
DEPAS (48 patients)
LAMOTRIGINE (47 patients)
CYMBALTA (47 patients)
RISPERDAL CONSTA (45 patients)
PLAVIX (44 patients)
ATENOLOL (44 patients)
LASIX (43 patients)
LAMIVUDINE (41 patients)
QUETIAPINE (41 patients)
NAMENDA (40 patients)
SERTRALINE HYDROCHLORIDE (40 patients)
PAROXETINE HCL (39 patients)
ACETAMINOPHEN (38 patients)
NEXIUM (38 patients)
WELLBUTRIN (37 patients)
LANSOPRAZOLE (37 patients)
VALPROATE SODIUM (37 patients)
LEXAPRO (37 patients)
ARIPIPRAZOLE (36 patients)
PREDNISOLONE (36 patients)
KLONOPIN (36 patients)
PRILOSEC (36 patients)
PROZAC (36 patients)
TRIHEXYPHENIDYL HCL (35 patients)
ESCITALOPRAM (34 patients)
RITONAVIR (33 patients)
INSULIN (33 patients)
MAGNESIUM OXIDE (33 patients)
RIVOTRIL (33 patients)
VIOXX (33 patients)
DIOVAN (32 patients)
RAMIPRIL (32 patients)
NEURONTIN (32 patients)
CLOZAPINE (32 patients)
CARBAMAZEPINE (32 patients)
AMANTADINE HCL (32 patients)
EXELON (32 patients)
FAMOTIDINE (32 patients)
DONEPEZIL HCL (32 patients)
SYMMETREL (31 patients)
ALBUTEROL (31 patients)
FOLIC ACID (31 patients)
FLUOXETINE (31 patients)
XANAX (31 patients)
ATIVAN (31 patients)
HYDROCHLOROTHIAZIDE (31 patients)
INVEGA (30 patients)
TRAZODONE HCL (30 patients)
MUCOSTA (29 patients)
METFORMIN HCL (29 patients)
CARBIDOPA AND LEVODOPA (28 patients)
NITROGLYCERIN (28 patients)
ALDACTONE (28 patients)
COZAAR (28 patients)
PREDNISONE (28 patients)
INVEGA SUSTENNA (27 patients)
REMERON (27 patients)
CYCLOSPORINE (27 patients)
ZESTRIL (27 patients)
ZANTAC (26 patients)
AMIODARONE HCL (26 patients)
DUROTEP (25 patients)
QUETIAPINE FUMARATE (25 patients)
CELEBREX (25 patients)
PEGASYS (25 patients)
ZOCOR (25 patients)
LANTUS (25 patients)
DOMPERIDONE (24 patients)
PROTONIX (24 patients)
VENLAFAXINE HCL (24 patients)
DURAGESIC-100 (24 patients)
PEPCID (23 patients)
CLOPIDOGREL (23 patients)
STALEVO 100 (23 patients)
FENTANYL (23 patients)
DOGMATYL (23 patients)
SULPIRIDE (23 patients)
BIPERIDEN HYDROCHLORIDE TAB (23 patients)
LEVAQUIN (23 patients)
RANITIDINE (23 patients)
TAMSULOSIN HCL (23 patients)
CELEXA (23 patients)
LITHIUM (23 patients)
CITALOPRAM (23 patients)
TEGRETOL (22 patients)
RIBAVIRIN (22 patients)
MEMANTINE HCL (22 patients)
AMITRIPTYLINE HCL (22 patients)
METHOTREXATE (22 patients)
ENALAPRIL MALEATE (21 patients)
XENAZINE (21 patients)
COGENTIN (21 patients)
SPIRONOLACTONE (21 patients)
SYNTHROID (21 patients)
SEROQUEL XR (20 patients)
KEPPRA (20 patients)
EFAVIRENZ (20 patients)
LUDIOMIL (20 patients)
REBETOL (20 patients)
AMOXICILLIN (20 patients)
OXAZEPAM (20 patients)
METOPROLOL SUCCINATE (19 patients)
DIVALPROEX SODIUM (19 patients)
MADOPAR (19 patients)
AMBIEN (19 patients)
CORDARONE (19 patients)
ROHYPNOL (19 patients)
NEVIRAPINE (19 patients)
ANAFRANIL (19 patients)
ZELDOX (19 patients)
BLOPRESS (18 patients)
TRILEPTAL (18 patients)
DUROTEP MT (18 patients)
AZITHROMYCIN (18 patients)
ZOLPIDEM TARTRATE (18 patients)
IMOVANE (18 patients)
PEG-INTRON (18 patients)
FLOMAX (18 patients)
ALLEGRA (18 patients)
METOPROLOL TARTRATE (18 patients)
OCTREOTIDE ACETATE (18 patients)
LENDORMIN (18 patients)
AZILECT (18 patients)
BETAFERON (18 patients)
SERENACE (18 patients)
REMICADE (17 patients)
TAVOR (17 patients)
ACTOS (17 patients)
DIDANOSINE (17 patients)
ATAZANAVIR SULFATE (17 patients)
ATAZANAVIR (17 patients)
PANTOPRAZOLE (17 patients)
ATORVASTATIN CALCIUM (17 patients)
FINASTERIDE (17 patients)
PAROXETINE HYDROCHLORIDE (17 patients)
GASMOTIN (17 patients)
PREVACID (17 patients)
ESCITALOPRAM OXALATE (17 patients)
MIRAPEX (16 patients)
FLUVOXAMINE MALEATE (16 patients)
PRECOSE (16 patients)
LEPONEX (16 patients)
SERTRALINE HCL (16 patients)
HALOPERIDOL DECANOATE (16 patients)
COUMADIN (16 patients)
PURSENNID (16 patients)
ALENDRONATE SODIUM (16 patients)
FLUCONAZOLE (16 patients)
CLINDAMYCIN (16 patients)
SAQUINAVIR (16 patients)
ALINAMIN F (16 patients)
PROCYCLIDINE HYDROCHLORIDE 2MG TAB (16 patients)
VITAMIN B-12 (16 patients)
GLUCOPHAGE (16 patients)
BENADRYL (15 patients)
LACTULOSE (15 patients)
ZIPRASIDONE HCL (15 patients)
IBUPROFEN (15 patients)
LOTREL (15 patients)
CANDESARTAN CILEXETIL (15 patients)
COMTAN (15 patients)
METOCLOPRAMIDE HCL (15 patients)
CRESTOR (15 patients)
ZOLPIDEM (15 patients)
SERTRALINE (15 patients)
Most common side effects for patients taking ALMARL:
DEPRESSED LEVEL OF CONSCIOUSNESS (20 patients)
HALLUCINATION (15 patients)
FALL (13 patients)
HYPOGLYCAEMIA (13 patients)
PYREXIA (12 patients)
TREMOR (12 patients)
DIARRHOEA (11 patients)
HEPATIC FUNCTION ABNORMAL (11 patients)
PNEUMONIA (10 patients)
DYSARTHRIA (10 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (9 patients)
RENAL FAILURE ACUTE (9 patients)
LIVER DISORDER (9 patients)
CEREBRAL INFARCTION (8 patients)
DISSEMINATED INTRAVASCULAR COAGULATION (8 patients)
DRUG INEFFECTIVE (8 patients)
RENAL IMPAIRMENT (8 patients)
HYPONATRAEMIA (8 patients)
INTERSTITIAL LUNG DISEASE (8 patients)
JAUNDICE (8 patients)
OEDEMA PERIPHERAL (8 patients)
CONDITION AGGRAVATED (7 patients)
DELIRIUM (7 patients)
DYSPHAGIA (7 patients)
DYSPNOEA (7 patients)
HYPOAESTHESIA (7 patients)
RHABDOMYOLYSIS (7 patients)
VOMITING (6 patients)
DELUSION (6 patients)
RESPIRATORY FAILURE (6 patients)
DYSKINESIA (6 patients)
SOMNOLENCE (6 patients)
HEPATIC NEOPLASM MALIGNANT (6 patients)
HYPERGLYCAEMIA (6 patients)
HYPOKALAEMIA (6 patients)
MOVEMENT DISORDER (6 patients)
MUSCULAR WEAKNESS (6 patients)
WHITE BLOOD CELL COUNT INCREASED (5 patients)
BLADDER CANCER (5 patients)
BLOOD ANTIDIURETIC HORMONE INCREASED (5 patients)
RESTLESSNESS (5 patients)
BLOOD OSMOLARITY DECREASED (5 patients)
PLEURAL EFFUSION (5 patients)
C-REACTIVE PROTEIN INCREASED (5 patients)
CONVULSION (5 patients)
RENAL DISORDER (5 patients)
VITH NERVE PARALYSIS (5 patients)
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION (5 patients)
INTESTINAL OBSTRUCTION (5 patients)
SEPSIS (5 patients)
ROAD TRAFFIC ACCIDENT (5 patients)
MUSCULOSKELETAL PAIN (5 patients)
NAUSEA (5 patients)
ANOREXIA (4 patients)
ATELECTASIS (4 patients)
ATRIAL FIBRILLATION (4 patients)
ATRIOVENTRICULAR BLOCK (4 patients)
BLOOD CREATININE INCREASED (4 patients)
BRADYCARDIA (4 patients)
CARDIAC FAILURE (4 patients)
CONSTIPATION (4 patients)
DECREASED APPETITE (4 patients)
DEHYDRATION (4 patients)
DIZZINESS (4 patients)
PLATELET COUNT DECREASED (4 patients)
PAIN (4 patients)
HYPERTENSION (4 patients)
HYPOTHYROIDISM (4 patients)
ILEUS (4 patients)
METABOLIC ACIDOSIS (4 patients)
SMALL INTESTINE CARCINOMA (4 patients)
URINE OSMOLARITY INCREASED (4 patients)
ABASIA (3 patients)
AGGRESSION (3 patients)
PRURITUS (3 patients)
ANAEMIA (3 patients)
PULMONARY ALVEOLAR HAEMORRHAGE (3 patients)
WHITE BLOOD CELL COUNT DECREASED (3 patients)
ASTHMA (3 patients)
BLOOD BILIRUBIN INCREASED (3 patients)
RENAL FAILURE (3 patients)
BLOOD PRESSURE DECREASED (3 patients)
BLOOD PRESSURE INCREASED (3 patients)
VASCULITIS (3 patients)
CAROTID ARTERY STENOSIS (3 patients)
THERAPEUTIC AGENT TOXICITY (3 patients)
CHILLS (3 patients)
CHROMATURIA (3 patients)
PETECHIAE (3 patients)
CHRONIC LYMPHOCYTIC LEUKAEMIA (3 patients)
PORIOMANIA (3 patients)
RENAL ARTERY STENOSIS (3 patients)
PANCYTOPENIA (3 patients)
DRUG ERUPTION (3 patients)
SUDDEN ONSET OF SLEEP (3 patients)
DRUG WITHDRAWAL SYNDROME (3 patients)
VERTIGO (3 patients)
EPILEPSY (3 patients)
FACE OEDEMA (3 patients)
VOLVULUS (3 patients)
GENERALISED OEDEMA (3 patients)
GINGIVAL BLEEDING (3 patients)
HAEMORRHAGE SUBCUTANEOUS (3 patients)
HALLUCINATION, VISUAL (3 patients)
PSYCHIATRIC SYMPTOM (3 patients)
HEART RATE DECREASED (3 patients)
HELICOBACTER TEST POSITIVE (3 patients)
HEPATITIS FULMINANT (3 patients)
HYPERKALAEMIA (3 patients)
HYPOTENSION (3 patients)
IDIOPATHIC THROMBOCYTOPENIC PURPURA (3 patients)
LOSS OF CONSCIOUSNESS (3 patients)
SENSORY DISTURBANCE (3 patients)
LYMPHOMA (3 patients)
MALAISE (3 patients)
MARKEDLY REDUCED DIETARY INTAKE (3 patients)
RENAL TUBULAR DISORDER (3 patients)
NEOPLASM MALIGNANT (3 patients)
SINUS ARREST (3 patients)
ABDOMINAL DISCOMFORT (2 patients)
ABDOMINAL PAIN (2 patients)
ACUTE MYELOID LEUKAEMIA (2 patients)
STOMACH MASS (2 patients)
PERSONALITY CHANGE (2 patients)
AGITATION (2 patients)
ALTERED STATE OF CONSCIOUSNESS (2 patients)
ANAPHYLACTOID REACTION (2 patients)
ANGER (2 patients)
PRODUCTIVE COUGH (2 patients)
RENAL CYST (2 patients)
APHASIA (2 patients)
ASTHENIA (2 patients)
ATRIOVENTRICULAR BLOCK COMPLETE (2 patients)
THIRST (2 patients)
PROSTATE CANCER (2 patients)
BLOOD AMYLASE INCREASED (2 patients)
BLOOD UREA INCREASED (2 patients)
BODY TEMPERATURE INCREASED (2 patients)
SPEECH DISORDER (2 patients)
TUMOUR LYSIS SYNDROME (2 patients)
CEREBRAL HAEMORRHAGE (2 patients)
CHEST X-RAY ABNORMAL (2 patients)
COLON CANCER (2 patients)
COMA HEPATIC (2 patients)
COMPLETED SUICIDE (2 patients)
CONTUSION (2 patients)
PERFORMANCE STATUS DECREASED (2 patients)
DEFAECATION URGENCY (2 patients)
DEMENTIA ALZHEIMER'S TYPE (2 patients)
RASH PRURITIC (2 patients)
DIABETIC KETOACIDOSIS (2 patients)
DRUG INTERACTION (2 patients)
DRUG LEVEL INCREASED (2 patients)
DYSPEPSIA (2 patients)
DYSSTASIA (2 patients)
ELECTROCARDIOGRAM QT PROLONGED (2 patients)
STEVENS-JOHNSON SYNDROME (2 patients)
EPULIS (2 patients)
EXTRAOCULAR MUSCLE PARESIS (2 patients)
FACIAL PARESIS (2 patients)
FEAR (2 patients)
FEBRILE NEUTROPENIA (2 patients)
FEMORAL NECK FRACTURE (2 patients)
FOOT FRACTURE (2 patients)
GAMMA-GLUTAMYLTRANSFERASE INCREASED (2 patients)
GANGRENE (2 patients)
GASTRIC ULCER HAEMORRHAGE (2 patients)
GINGIVAL HYPERTROPHY (2 patients)
GLOSSOPTOSIS (2 patients)
PLEURISY (2 patients)
PHRENIC NERVE PARALYSIS (2 patients)
HAEMATEMESIS (2 patients)
HAEMATURIA (2 patients)
HAEMOGLOBIN DECREASED (2 patients)
POLLAKIURIA (2 patients)
ORAL INTAKE REDUCED (2 patients)
HEPATIC CYST (2 patients)
HEPATIC ENCEPHALOPATHY (2 patients)
HEPATITIS (2 patients)
HYPERREFLEXIA (2 patients)
HYPERTONIA (2 patients)
HYPERURICAEMIA (2 patients)
RASH PAPULAR (2 patients)
INITIAL INSOMNIA (2 patients)
RETINAL OEDEMA (2 patients)
INTESTINAL FUNCTIONAL DISORDER (2 patients)
RESPIRATION ABNORMAL (2 patients)
IRRITABILITY (2 patients)
RIB FRACTURE (2 patients)
LEG AMPUTATION (2 patients)
LYMPHADENOPATHY (2 patients)
METABOLIC ALKALOSIS (2 patients)
ORAL HERPES (2 patients)
TAKAYASU'S ARTERITIS (2 patients)
MOUTH HAEMORRHAGE (2 patients)
UNRESPONSIVE TO STIMULI (2 patients)
TOXIC SKIN ERUPTION (2 patients)
NEPHROLITHIASIS (2 patients)
SUICIDE ATTEMPT (2 patients)
VENTRICULAR FIBRILLATION (2 patients)
NEUTROPHIL COUNT DECREASED (2 patients)
UPPER RESPIRATORY TRACT INFECTION (2 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (2 patients)
SHOCK HAEMORRHAGIC (2 patients)
ABDOMEN CRUSHING (1 patients)
CARDIAC FAILURE CONGESTIVE (1 patients)
EOSINOPHILIC PNEUMONIA ACUTE (1 patients)
ESSENTIAL TREMOR (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)
FUNGAL INFECTION (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ALMARL


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about PARKINSONISM and ALMARL, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ALMARL, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ALMARL. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ALMARL experts. If you are a healthcare provider experienced in prescribing ALMARL, please register here.

Your online appointment book for Flower Mound Rentals & Services

Chef and Catering services in Flower Mound
Chiropracter and Massage services in Flower Mound
Event and Wedding Planning services in Flower Mound
Hair Styling services in Flower Mound
Personal Shopping services in Flower Mound
Photography and Videography services in Flower Mound
Private Investigation services in Flower Mound
Website Design services in Flower Mound

Home
Appliance Repair services in Flower Mound
Appraisals services in Flower Mound
Awnings services in Flower Mound
Builder Services services in Flower Mound
Carpentry services in Flower Mound
Cleaning services in Flower Mound
Decks and Porches services in Flower Mound
Electricians services in Flower Mound
Fireplace services in Flower Mound
Generators services in Flower Mound
Greenhouses and Nurseries services in Flower Mound
Handymen services in Flower Mound
Home Security services in Flower Mound
HVAC services in Flower Mound
Insulation services in Flower Mound
Interior Design services in Flower Mound
Landscaping services in Flower Mound
Lawn and Yard services in Flower Mound
Locksmiths services in Flower Mound
Marble and Granite Experts services in Flower Mound
Masonry services in Flower Mound
Moving Services services in Flower Mound
Painters services in Flower Mound
Plumbing services in Flower Mound
Pool and Spa services in Flower Mound
Property Management services in Flower Mound
Roofers services in Flower Mound
Snow Plowing services in Flower Mound
Solar Power Consultants services in Flower Mound
Upholstery services in Flower Mound
Wallpaper services in Flower Mound
Waterproofing services in Flower Mound
Windows services in Flower Mound
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use